drugset / Trial / NCT03220958

Metoclopramide for Post Traumatic Headache

NCT03220958

Phase 3 Completed 160 enrolled Montefiore Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Nearly 1.5 million patients present to US emergency departments annually following head trauma. Headache is a frequent symptom of victims of head trauma. The purpose of this study is to see if an intravenous medication called metoclopramide can improve the symptoms of patients with acute post-traumatic headache.

Timeline

Start
2017-08-01
Primary completion
2020-04-01
Completion
2020-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Metoclopramide Small molecule 20 mg Intravenous
Background Diphenhydramine Unknown 25 mg Intravenous